Bratschi advised UBS Switzerland, acting as mandated lead arranger, agent and security agent, in connection with a syndicated financing for SwissTech Watch Components SA (STWC), a Swiss industrial group specialising in the design and manufacture of high-precision components for the luxury watchmaking industry. The financing supports STWC’s acquisition of Rouages, a Swiss company founded in […]
Advestra advised UBS Switzerland as mandated lead arranger, coordinator, agent and lender together with the other syndicate banks as lenders on the credit facilities provided to DT Swiss Holding. The DT Swiss Group is a
Banking & Finance
Homburger with InstallatørGruppen and syndicate banks on credit facilities refinancing
Homburger advised the syndicate of banks and InstallatørGruppen on the refinancing of InstallatørGruppen’s credit facilities in connection with InstallatørGruppen A/S’ initial public offering and listing on Nasdaq Copenhagen. The refinancing
Walder Wyss advised Glarner Kantonalbank on the issuance of CHF 125 million tier 2 bonds with a 1.55% coupon at an issue price of 100.048%. The bonds have a ten-year term to 2 July 2036 and are callable after five years.
Siegfried Holding, a Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, entered into a CHF 650 m term and revolving facilities agreement, with UBS Switzerland acting as mandated lead arranger, coordinator and agent. In
Walder Wyss advised funds managed by Pharmakon Advisors — an investor in non-dilutive debt for the life sciences industry and the investment manager of the BioPharma Credit funds — in connection with their role as investors in
Advestra advised Zürcher Kantonalbank as coordinator, agent and lender, as well as the other members of the banking syndicate, on the investment financing for Spitäler Schaffhausen. Together with the subordinated loan from the
Kellerhals Carrard advised Spitäler Schaffhausen (as borrower) on a customized financing transaction including a subordinated credit agreement of CHF 60 million with the Canton Schaffhausen and a credit facility agreement of CHF 100 million with a
Homburger advised Siegfried Holding in connection with the bridge financing for the acquisition of three drug substances sites in the US and Australia. The context On May 1, 2026, Siegfried Holding, a globally active Contract Development and
Homburger has advised UBS Switzerland AG in connection with Bachem Holding's new CHF 500 million revolving credit facility, with a team spanning financing and tax practices.
